Skip to content

Delifab

Active Private limited companyfounded 2021active for 5 yearsHendrik Drapsstraat 35, 1853 GrimbergenKBO/BCE: BE 0761.863.140 #8 company by staff growth in Grimbergen

Board

1 director, no change since 2025
Director, permanent representative
since 21-01-2021
also on the board of 1 other company
listed in the 2026 annual accounts, filed on 29-10-2026
Permanent representatives 1
Permanent representative, for
appointed by deed of 04-09-2025

Office holders in the KBO →

Mandates through the years

1 name, the dashed line is today

Director
Board
Mandates as a list
    • Director, from 21-01-2021 to date
With Starter you also see 1 former office holder in the mandate history. See the plans →

Control

Founder
This company
Delifab
Equity €239,819
Profit €45,643 in 2026

Capital

Contribution
€20,000
Shares
200
Contribution per share
€100
Equity per share
€1,199 in 2026
Source
deed of 25-01-2021

Articles of association

deed of 25-01-2021 (in Dutch)
DurationMost companies exist for an unlimited period, until they are dissolved.
Unlimited
Board ruleThese rules set how the board is made up, meets and takes decisions.
At least 1 director
Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
“Titel V - Algemene vergadering Artikel 16. Organisatie en bijeenroeping Ieder jaar wordt een gewone algemene vergadering van aandeelhouders…”

Shareholders

At incorporation deed of 25-01-2021 ↗
  • 2,000 shares · €20,000

Next steps